EXECUTIVE PROFILE
Charles Homcy, MD, Chairman, Third Rock Ventures
Share this profile
CHARLES HOMCY, MD, CHAIRMAN, THIRD ROCK VENTURES BACKGROUND / BIOGRAPHY
-
- Charles Homcy joined Third Rock Ventures in 2010 as a Venture Partner. Charles co-founded Portola Pharmaceuticals in 2003, and served as President and Chief Executive Officer from that time until April 2010. Prior to that, he was President of Research and Development at Millennium following Millennium's acquisition of COR Therapeutics in 2002. Charles joined COR in 1995 as Executive Vice President of Research and Development, and he served as a Director of the company from 1998 to 2002. He has been a clinical professor of medicine at the University of California, San Francisco Medical School, and attending physician at the San Francisco VA Hospital since 1997. He was previously President of the medical research division of American Cyanamid-Lederle Laboratories, a division of Wyeth. Charles serves as co-chairman of the board of directors of Portola and is a board member of Geron Corporation. Charles received his AB and MD from Johns Hopkins University.
- Charles Homcy joined Third Rock Ventures in 2010 as a Venture Partner. Charles co-founded Portola Pharmaceuticals in 2003, and served as President and Chief Executive Officer from that time until April 2010. Prior to that, he was President of Research and Development at Millennium following Millennium's acquisition of COR Therapeutics in 2002. Charles joined COR in 1995 as Executive Vice President of Research and Development, and he served as a Director of the company from 1998 to 2002. He has been a clinical professor of medicine at the University of California, San Francisco Medical School, and attending physician at the San Francisco VA Hospital since 1997. He was previously President of the medical research division of American Cyanamid-Lederle Laboratories, a division of Wyeth. Charles serves as co-chairman of the board of directors of Portola and is a board member of Geron Corporation. Charles received his AB and MD from Johns Hopkins University.
-
- COMPANY
- CytomX Therapeutics
-
- TITLE
- Board of Directors
-
- COMPANY ADDRESS
- 650 Gateway Blvd
South San Francisco, CA 94080
United States
LEARN MORE ABOUT CHARLES HOMCY, MD, CHAIRMAN, THIRD ROCK VENTURES
If interested in more biographies and information for over 500,000 executives, and investors, visit CB Insights.
